Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan 80/HCTZ 25 Follow-up in Hypertension
NCT00267943Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 16
01
Overview
Phase 3, open-label, single-arm trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Primary endpoint: Proportion of patients achieving diastolic blood pressure (DBP) control at 6 months. Started Jan 2006; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00267943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267943.